Related Experiment Videos
Adverse drug reactions/interactions in maintenance therapy
1Department of Clinical Investigation and Regulatory Affairs (Psychopharmacology), Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN 46285.
The Journal of Clinical Psychiatry
|August 1, 1993
Summary
Long-term maintenance therapy is crucial for recurrent major depression. Selective serotonin reuptake inhibitors (SSRIs) offer a favorable risk-benefit profile, with fluoxetine demonstrating manageable adverse events during chronic use and upon discontinuation.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- Recurrent major depression poses significant challenges due to early onset and recidivism.
- Long-term maintenance therapy is increasingly recognized as essential for managing recurrent depression.
- Optimizing the risk:benefit ratio is key for successful patient maintenance.
Purpose of the Study:
- To review the role of maintenance therapy in recurrent major depression.
- To evaluate the safety and tolerability of antidepressants, particularly SSRIs.
- To examine fluoxetine's adverse event profile in short- and long-term use and after discontinuation.
Main Methods:
- Literature review of early-onset depression, recidivism, and consequences.
- Analysis of adverse event data from antidepressant trials (short- and long-term).
- Review of drug-drug interactions, focusing on cytochrome P450 IID6.
Main Results:
- SSRIs show lower discontinuation rates due to adverse events than conventional antidepressants.
- Fluoxetine's adverse events do not increase with chronic administration and typically emerge early, waning with continued treatment.
- Discontinuation adverse events for fluoxetine usually reverse faster than its half-life.
Conclusions:
- Maintenance therapy is critical for recurrent major depression.
- Minimizing adverse drug events and patient education are vital for optimizing compliance and therapeutic outcomes.
- Clinicians must address psychosocial factors alongside pharmacotherapy for comprehensive patient care.